Estrogen receptor of primary breast cancers: evidence for intracellular proteolysis

AUTOR(ES)

Maaroufi, Younes

FONTE

BioMed Central

RESUMO

Iodinated oestradiol-labeled oestrogen receptor (ER) isoforms devoid of amino-terminal ABC domains represent about two-thirds of the whole receptor population detected in cytosol samples from human breast cancers. This high frequency could not be ascribed to the expression of truncated mRNAs, or to the proteolysis of the native ER peptide at the time of homogenization or assay, suggesting an intracellular proteolysis. Free amino-terminal and ligand-binding domains maintained together within oligomeric structure(s); increase of ionic strength separated them. The amino-terminal region was consistently detected in the cell nucleus by specific immunohistochemistry leading to the concept of a potential intranuclear association between ER cleavage products and/or other regulatory proteins.

Documentos Relacionados

• A transcriptional enhancer required for the differential expression of the human estrogen receptor in breast cancers.
• Expression of Fas (CD95/APO-1) Ligand by Human Breast Cancers: Significance for Tumor Immune Privilege
• Synchronous primary lung cancers: prevalence in surgical material and clinical implications.
• The nuclear factor kappa B (NF-κB): A potential therapeutic target for estrogen receptor negative breast cancers
• MULTIPLE PRIMARY CANCERS: PRIMARY MALIGNANT LYMPHOMAS AND CARCINOMAS OF THE INTESTINAL TRACT IN THE SAME PATIENT